These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23313996)

  • 1. Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
    Sarkissian A; Neher JO; Singh R; St Anna L
    J Fam Pract; 2012 Dec; 61(12):759-72. PubMed ID: 23313996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
    Bordeleau L; Pritchard KI; Loprinzi CL; Ennis M; Jugovic O; Warr D; Haq R; Goodwin PJ
    J Clin Oncol; 2010 Dec; 28(35):5147-52. PubMed ID: 21060031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gabapentin in patients experiencing hot flashes.
    Brown JN; Wright BR
    Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation nonhormonal management for hot flashes.
    Imai A; Matsunami K; Takagi H; Ichigo S
    Gynecol Endocrinol; 2013 Jan; 29(1):63-6. PubMed ID: 22809093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy: nonhormonal treatment of hot flashes-a viable alternative?
    Nachtigall LE
    Nat Rev Endocrinol; 2010 Feb; 6(2):66-7. PubMed ID: 20098445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
    Toulis KA; Tzellos T; Kouvelas D; Goulis DG
    Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.
    Barton D; La Vasseur B; Loprinzi C; Novotny P; Wilwerding MB; Sloan J
    Oncol Nurs Forum; 2002; 29(1):33-40. PubMed ID: 11817491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hot flashes in breast cancer survivors and men with prostate cancer.
    Stearns V
    Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors.
    Lavigne JE; Heckler C; Mathews JL; Palesh O; Kirshner JJ; Lord R; Jacobs A; Amos E; Morrow GR; Mustian K
    Breast Cancer Res Treat; 2012 Nov; 136(2):479-86. PubMed ID: 23053645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
    Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ
    Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.
    Prelle K; Igl BW; Obendorf M; Girbig D; Lehmann T; Patchev VK
    Menopause; 2012 Aug; 19(8):909-15. PubMed ID: 22473248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial.
    Garland SN; Xie SX; Li Q; Seluzicki C; Basal C; Mao JJ
    Menopause; 2017 May; 24(5):517-523. PubMed ID: 27875389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
    Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
    Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Inquiry: Which nonhormonal treatments are effective for hot flashes?
    Kelsberg G; Maragh L; Safranek S
    J Fam Pract; 2016 May; 65(5):E1-3. PubMed ID: 27275942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical update: new treatments for hot flushes.
    Stearns V
    Lancet; 2007 Jun; 369(9579):2062-4. PubMed ID: 17586289
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hot flashes in palliative care. Part 2 #262.
    Lefkowits CC; Arnold RM
    J Palliat Med; 2013 Jan; 16(1):101-2. PubMed ID: 23317326
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis.
    Yamaguchi N; Okajima Y; Fujii T; Natori A; Kobayashi D
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1701-7. PubMed ID: 23974271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What can be done about hot flushes after treatment for breast cancer?
    Kontos M; Agbaje OF; Rymer J; Fentiman IS
    Climacteric; 2010 Feb; 13(1):4-21. PubMed ID: 20067430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia.
    Parsons B; Tive L; Huang S
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.